Exposure to TNF inhibitors is rare at MOGAD presentation

J Neurol Sci. 2022 Jan 15:432:120044. doi: 10.1016/j.jns.2021.120044. Epub 2021 Oct 27.
No abstract available

Keywords: Adverse event; Demyelination; MOGAD; Myelin oligodendrocyte glycoprotein; Tumor necrosis factor.

Publication types

  • Letter

MeSH terms

  • Autoantibodies
  • Humans
  • Myelin-Oligodendrocyte Glycoprotein
  • Neuromyelitis Optica*
  • Tumor Necrosis Factor Inhibitors*

Substances

  • Autoantibodies
  • Myelin-Oligodendrocyte Glycoprotein
  • Tumor Necrosis Factor Inhibitors